End-to-end personalized therapy design combining target identification, asset generation, and validation.
{
"tumor_profile": {
"mutations": [
"KRAS G12C",
"TP53 R273H"
],
"cancer_type": "NSCLC",
"stage": "metastatic"
},
"therapeutic_modalities": [
"small_molecule",
"immunotherapy",
"gene_therapy"
]
}/analyze_cancer_hallmarks
/design_personalized_therapy
/generate_therapeutic_protein